FOXO FOXO Technologies Inc.: Business Value

FOXO Technologies (FOXO) generates revenue through data analysis and molecular testing to determine risks within the life insurance sector. The company implements epigenetics and AI to assess longevity, targeting the biomarker underwriting market. Cloud-based analysis systems operate without hardware depreciation due to software scaling. Serving as the primary valuation tool, this chart on GURU.Markets shows an Enterprise Value of .

Fundamental asset selection requires an analysis of the actual acquisition cost, which combines market capitalization with net debt to uncover hidden liabilities. This metric determines the actual price of the business, which for the asset-light model of FOXO (FOXO) and its AI licensing implies valuation transparency without the burden of heavy assets, as clearly reflected in the enterprise value history.